➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Moodys
Mallinckrodt
Merck
Johnson and Johnson

Last Updated: February 28, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ANAGRELIDE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Anagrelide Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00175838 Primary Thrombocythaemia 1 Trial Active, not recruiting Cambridge University Hospitals NHS Foundation Trust N/A 1997-07-01 The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients.
NCT00175838 Primary Thrombocythaemia 1 Trial Active, not recruiting Institute of Cancer Research, United Kingdom N/A 1997-07-01 The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients.
NCT00175838 Primary Thrombocythaemia 1 Trial Active, not recruiting University of Cambridge N/A 1997-07-01 The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Anagrelide Hydrochloride

Condition Name

Condition Name for Anagrelide Hydrochloride
Intervention Trials
Essential Thrombocythemia 5
Essential Thrombocythaemia 4
Healthy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Anagrelide Hydrochloride
Intervention Trials
Thrombocytosis 16
Thrombocythemia, Essential 16
Polycythemia Vera 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Anagrelide Hydrochloride

Trials by Country

Trials by Country for Anagrelide Hydrochloride
Location Trials
United States 53
Japan 18
Germany 11
France 7
Italy 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Anagrelide Hydrochloride
Location Trials
North Carolina 4
Arizona 4
Pennsylvania 4
California 4
New York 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Anagrelide Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Anagrelide Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 8
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Anagrelide Hydrochloride
Clinical Trial Phase Trials
Completed 10
Recruiting 5
Not yet recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Anagrelide Hydrochloride

Sponsor Name

Sponsor Name for Anagrelide Hydrochloride
Sponsor Trials
Shire 6
Roche Pharma AG 3
AOP Orphan Pharmaceuticals AG 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Anagrelide Hydrochloride
Sponsor Trials
Industry 23
Other 12
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Baxter
Harvard Business School
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.